Evommune (EVMN) Non-Current Assets (2024 - 2026)

Evommune (EVMN) has reported Non-Current Assets for 3 consecutive years, with $106.6 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Non-Current Assets changed N/A year-over-year to $106.6 million; the TTM figure through Mar 2026 stood at $182.7 million (changed N/A YoY), while the FY2025 annual figure was $71.5 million, up 3357.57% from the prior year.
• Non-Current Assets advanced to $106.6 million in Q1 2026 per EVMN's latest filing, from $71.5 million in the prior quarter.
• Across five years, Non-Current Assets topped out at $106.6 million in Q1 2026 and bottomed at $2.1 million in Q4 2024.
• Historically, Non-Current Assets has averaged $45.7 million across 3 years, with a median of $37.0 million in 2025.
• On a YoY basis, Non-Current Assets climbed as much as 3357.57% in 2025 and fell as far as 3357.57% in 2025.
• Evommune's Non-Current Assets stood at $2.1 million in 2024, then surged by 3357.57% to $71.5 million in 2025, then soared by 49.16% to $106.6 million in 2026.
• Business Quant data shows EVMN's Non-Current Assets at $106.6 million in Q1 2026, $71.5 million in Q4 2025, and $2.6 million in Q3 2025.